Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Other Non-Current Assets: 2023-2025

Historic Other Non-Current Assets for Artiva Biotherapeutics (ARTV) over the last 3 years, with Sep 2025 value amounting to $461,000.

  • Artiva Biotherapeutics' Other Non-Current Assets rose 78.68% to $461,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $461,000, marking a year-over-year increase of 78.68%. This contributed to the annual value of $267,000 for FY2024, which is 31.89% down from last year.
  • As of Q3 2025, Artiva Biotherapeutics' Other Non-Current Assets stood at $461,000, which was down 0.00% from $461,000 recorded in Q2 2025.
  • In the past 5 years, Artiva Biotherapeutics' Other Non-Current Assets ranged from a high of $461,000 in Q1 2025 and a low of $258,000 during Q2 2023.
  • Its 3-year average for Other Non-Current Assets is $333,200, with a median of $262,500 in 2023.
  • Per our database at Business Quant, Artiva Biotherapeutics' Other Non-Current Assets plummeted by 31.89% in 2024 and then surged by 78.68% in 2025.
  • Artiva Biotherapeutics' Other Non-Current Assets (Quarterly) stood at $392,000 in 2023, then crashed by 31.89% to $267,000 in 2024, then spiked by 78.68% to $461,000 in 2025.
  • Its Other Non-Current Assets stands at $461,000 for Q3 2025, versus $461,000 for Q2 2025 and $461,000 for Q1 2025.